MedTrace Logo

Regional Lymph Node Irradiation for High-risk pN0 Breast Cancer

NCT05976412 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1355

Last updated 2023-08-07

No results posted yet for this study

Summary

This study is a non blind, randomized controlled study, whose hypothesis was that chest wall/whole breast combined regional lymph node radiotherapy can improve the 5-year disease-free survival rate of clinical high-risk pN0 breast cancer patients.

Conditions

Interventions

RADIATION

Regional lymph node radiotherapy

Regional lymph node radiotherapy

RADIATION

chest/whole breast irradiation

chest/whole breast irradiation

Sponsors & Collaborators

  • Ruijin Hospital

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-07-28
Primary Completion
2031-05-31
Completion
2031-05-31

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05976412 on ClinicalTrials.gov